thiotepa has been researched along with Antidiuretic Hormone, Inappropriate Secretion in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleta, R | 1 |
| Wagner, A | 1 |
| Jürgens, H | 1 |
| Sica, S | 1 |
| Cicconi, S | 1 |
| Sorà, F | 1 |
| Chiusolo, P | 1 |
| Piccirillo, N | 1 |
| Laurenti, L | 1 |
| La Barbera, EO | 1 |
| Giordano, G | 1 |
| Leone, G | 1 |
2 other studies available for thiotepa and Antidiuretic Hormone, Inappropriate Secretion
| Article | Year |
|---|---|
Recurrence of SIADH after a high-dose regimen of thiotepa, carboplatin, and etoposide phosphate.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot | 1998 |
Inappropriate antidiuretic hormone secretion after high-dose thiotepa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; C | 1999 |